Literature DB >> 15551290

Cytokine profile of sickle cell disease in Oman.

Anil Pathare1, Salam Al Kindi, Adel Alwan Alnaqdy, Shahina Daar, Huxley Knox-Macaulay, David Dennison.   

Abstract

The aim of our study was to assess the cytokine profile of sickle cell disease (SCD) patients in steady state and in vaso-occlusive crisis (VOC). VOC has a complex nature, involving interactions between sickle red blood cells (RBC), the endothelium, and leucocytes. Endothelial damage due to recurrent adhesion of sickle RBCs may disrupt endothelial function, leading to altered cytokine release. It is therefore pertinent to study the cytokine profile of SCD patients in steady state and in crisis prior to exploring its contribution to vaso-occlusive manifestations, since it is believed that an altered balance of proinflammatory and anti-inflammatory cytokines plays an important role in painful crisis. Cytokines including IL-1beta, IL-2, IL-4, IL-6, IL-8, TNF-alpha, and IFN-gamma were measured by commercially available ELISA kits in SCD patients (n = 60); in steady state (n = 26) and in painful crisis (n = 34) and compared with nonanemic age- and sex-matched normal Omani controls (n = 20). SCD patients in crisis showed elevated levels of TNF-alpha (P < 0.092) and IL-6 (P < 0.024) when compared with steady state. It was also observed that SCD patients in steady state showed a significant elevation in IL-1beta (P < 0.04), IL-6 (P < 0.0001), and IFN-gamma (P < 0.02) as compared to normal subjects. It is thus evident that both type I and type II cytokines are significantly altered in SCD patients. In steady state, type II proinflammatory cytokines are elevated, whereas in crisis, an additional augmentation of type I cytokines occurs, with persistent elevation of type II cytokines, emphasizing the role of perturbed endothelium and activated monocytes in the pathophysiology of vaso-occlusion in sickle cell crisis. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551290     DOI: 10.1002/ajh.20196

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  56 in total

1.  High levels of neopterin and interleukin-3 in sickle cell disease patients.

Authors:  L Rodrigues; F F Costa; S T O Saad; H Z W Grotto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease.

Authors:  Shushan Zhao; Morayo G Adebiyi; Yujin Zhang; Jacob P Couturier; Xuegong Fan; Hongqi Zhang; Rodney E Kellems; Dorothy E Lewis; Yang Xia
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

3.  The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Authors:  Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

4.  Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.

Authors:  Robert S Nickel; Ifeyinwa Osunkwo; Aneesah Garrett; Jennifer Robertson; David R Archer; Daniel E L Promislow; John T Horan; Jeanne E Hendrickson; Leslie S Kean
Journal:  Br J Haematol       Date:  2015-03-05       Impact factor: 6.998

5.  Prevalence and Clinical Characteristics of Rheumatoid Arthritis in an Inner City Population with Sickle Cell Disease.

Authors:  Isabel M McFarlane; David J Ozeri; Joshy Pathiparampil; Randolph Sanchez; Justin Levinson; Odeth Barrett-Campbell; Carla Saladini-Aponte; Beatrix Boisette; Moro Salifu
Journal:  Rheumatology (Sunnyvale)       Date:  2017-04-28

6.  TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.

Authors:  Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-26

7.  Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.

Authors:  Selma Unal; Ozlem Ozdemir; Ahmet Ata Ozcimen; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-12-06       Impact factor: 2.490

8.  Cysteine-iron promotes arginase activity by driving the Fenton reaction.

Authors:  Efemwonkiekie W Iyamu; Harrison Perdew; Gerald M Woods
Journal:  Biochem Biophys Res Commun       Date:  2008-08-30       Impact factor: 3.575

Review 9.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

10.  Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

Authors:  Joshua J Field; Gene Lin; Maureen M Okam; Elaine Majerus; Jeffrey Keefer; Onyinye Onyekwere; Ainsley Ross; Federico Campigotto; Donna Neuberg; Joel Linden; David G Nathan
Journal:  Blood       Date:  2013-02-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.